C. Edgerly

The Wnt Receptor Ryk Reduces Neuronal and Cell Survival Capacity by Repressing FOXO Activity During the Early Phases of Mutant Huntingtin Pathogenicity

Jean-Philippe Vert, Wange Lu, Christian Neri, 2014, PLoS biology.

Defining the role of syndecan-4 in mechanotransduction using surface-modification approaches

Chao-Min Cheng, Philip R. LeDuc, Jeffrey J. Fredberg, 2009, Proceedings of the National Academy of Sciences.

Reduced creatine kinase as a central and peripheral biomarker in Huntington's disease.

H. D. Rosas, S. Hersch, R. Ferrante, 2010, Biochimica et biophysica acta.

Uridine ameliorates the pathological phenotype in transgenic G93A-ALS mice

R. Ferrante, Jinho Kim, Kerry A. Cormier, 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

Correction to "Chiral Cyclohexane 1,3-Diones as Inhibitors of Mutant SOD1-Dependent Protein Aggregation for the Treatment of ALS".

Wei Zhang, R. Ferrante, R. Morimoto, 2017, ACS medicinal chemistry letters.

Chiral cyclohexane 1,3-diones as inhibitors of mutant SOD1-dependent protein aggregation for the treatment of ALS.

R. Ferrante, R. Morimoto, Jinho Kim, 2012, ACS medicinal chemistry letters.

Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.

M. Beal, R. Ferrante, Jinho Kim, 2010, Human molecular genetics.

The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models.

S. Hersch, R. Ferrante, Jinho Kim, 2012, Cell reports.